These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33930553)

  • 1. Systemic sclerosis biomarkers detection in the secretome of TGFβ1-activated primary human lung fibroblasts.
    Kendall RT; Renaud L; Baatz JE; Malaab M; Nguyen XX; Feghali-Bostwick CA
    J Proteomics; 2021 Jun; 242():104243. PubMed ID: 33930553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis.
    Del Galdo F; Shaw MA; Jimenez SA
    Am J Pathol; 2010 Oct; 177(4):1638-46. PubMed ID: 20724591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First Characterization of the Transcriptome of Lung Fibroblasts of SSc Patients and Healthy Donors of African Ancestry.
    Renaud L; Waldrep KM; da Silveira WA; Pilewski JM; Feghali-Bostwick CA
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers.
    Landi C; Bargagli E; Carleo A; Refini RM; Bennett D; Bianchi L; Cillis G; Prasse A; Bini L; Rottoli P
    Rheumatology (Oxford); 2019 Jan; 58(1):165-178. PubMed ID: 30239835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Antiretroviral Agent Nelfinavir Mesylate: A Potential Therapy for Systemic Sclerosis.
    Sanchez CG; Molinski SV; Gongora R; Sosulski M; Fuselier T; MacKinnon SS; Mondal D; Lasky JA
    Arthritis Rheumatol; 2018 Jan; 70(1):115-126. PubMed ID: 28940894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension.
    Hsu E; Shi H; Jordan RM; Lyons-Weiler J; Pilewski JM; Feghali-Bostwick CA
    Arthritis Rheum; 2011 Mar; 63(3):783-94. PubMed ID: 21360508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Fibronectin Levels in Profibrotic CD14
    Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
    Front Immunol; 2021; 12():642891. PubMed ID: 34504485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Secretome Analysis of Activated Human Renal Fibroblasts Revealed Beneficial Effect of the Modulation of the Secreted Peptidyl-Prolyl Cis-Trans Isomerase A in Kidney Fibrosis.
    Dihazi GH; Eltoweissy M; Jahn O; Tampe B; Zeisberg M; Wülfrath HS; Müller GA; Dihazi H
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration.
    Bogatkevich GS; Ludwicka-Bradley A; Singleton CB; Bethard JR; Silver RM
    Am J Physiol Lung Cell Mol Physiol; 2008 Oct; 295(4):L603-11. PubMed ID: 18676875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory Regulation of Skin Fibrosis in Systemic Sclerosis by Apelin/APJ Signaling.
    Yokoyama Y; Sekiguchi A; Fujiwara C; Uchiyama A; Uehara A; Ogino S; Torii R; Ishikawa O; Motegi SI
    Arthritis Rheumatol; 2018 Oct; 70(10):1661-1672. PubMed ID: 29676521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis.
    Rozier P; Maumus M; Bony C; Maria ATJ; Sabatier F; Jorgensen C; Guilpain P; Noël D
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodelling.
    Almeida SFF; Santos L; Sampaio-Ribeiro G; Ferreira HRS; Lima N; Caetano R; Abreu M; Zuzarte M; Ribeiro AS; Paiva A; Martins-Marques T; Teixeira P; Almeida R; Casanova JM; Girão H; Abrunhosa AJ; Gomes CM
    J Exp Clin Cancer Res; 2023 Nov; 42(1):328. PubMed ID: 38031171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [THE ROLE OF SEMAPHORIN 7A IN SYSTEMIC SCLEROSIS].
    Rimar D; Slobodin G; Rosner I; Rozenbaum M; Kaly L; Boulman N; Jiries N; Awisat A; Vadasz Z
    Harefuah; 2017 Jul; 156(7):418-421. PubMed ID: 28786275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in matrix metalloproteinase‑3 activity in systemic sclerosis fibroblasts causes α2‑antiplasmin and extracellular matrix deposition, and contributes to fibrosis development.
    Niwa H; Kanno Y; Shu E; Seishima M
    Mol Med Rep; 2020 Oct; 22(4):3001-3007. PubMed ID: 32945390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease.
    Jung SM; Park KS; Kim KJ
    Ann Rheum Dis; 2022 Jan; 81(1):108-116. PubMed ID: 34380701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease.
    Lindahl GE; Stock CJ; Shi-Wen X; Leoni P; Sestini P; Howat SL; Bou-Gharios G; Nicholson AG; Denton CP; Grutters JC; Maher TM; Wells AU; Abraham DJ; Renzoni EA
    Respir Res; 2013 Aug; 14(1):80. PubMed ID: 23915349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Analysis Reveals Differential Expression Profiles in Idiopathic Pulmonary Fibrosis Cell Lines.
    Velázquez-Enríquez JM; Ramírez-Hernández AA; Navarro LMS; Reyes-Avendaño I; González-García K; Jiménez-Martínez C; Castro-Sánchez L; Sánchez-Chino XM; Vásquez-Garzón VR; Baltiérrez-Hoyos R
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic Analysis of Human Scleroderma Fibroblasts Response to Transforming Growth Factor-ß.
    Chaigne B; Clary G; Le Gall M; Dumoitier N; Fernandez C; Lofek S; Chafey P; Moinzadeh P; Krieg T; Denton CP; Mouthon L
    Proteomics Clin Appl; 2019 Jul; 13(4):e1800069. PubMed ID: 30141531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways.
    Hsu E; Feghali-Bostwick CA
    Am J Pathol; 2008 Jun; 172(6):1580-90. PubMed ID: 18467708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of extracellular vesicles and conditioned medium from human adipose-derived stem/stromal cells and dermal fibroblasts.
    Niada S; Giannasi C; Magagnotti C; Andolfo A; Brini AT
    J Proteomics; 2021 Feb; 232():104069. PubMed ID: 33309826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.